Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Pricing
Podcast Image

Breakfast Business with Joe Lynam

Poolbeg Pharma on a a new cancer immunity

30 Jul 2025

Description

Poolbeg Pharma, named after the infamous Red & white towers has been working on some very exciting new ideas including a new cancer immunity drug and a potential weight loss tablet. But most early drug developments fail to make it to the final round of testing on humans because it’s so risky and so expensive.  And what does a pharma company like Poolbeg make of the EU-US trade deal with its 15% tariffs thus far? Jeremy Skillington, is the chief executive of Poolbeg pharma and joined Joe Lynam on the show this morning.

Audio
Featured in this Episode

No persons identified in this episode.

Transcription

This episode hasn't been transcribed yet

Help us prioritize this episode for transcription by upvoting it.

0 upvotes
🗳️ Sign in to Upvote

Popular episodes get transcribed faster

Comments

There are no comments yet.

Please log in to write the first comment.